Asthalin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asthalin

What is Asthalin?

Asthalin is a pharmaceutical preparation containing the active ingredient salbutamol (also known as albuterol). It belongs to a class of medications known as selective beta-2 adrenergic agonists, which are primarily used to manage respiratory conditions characterized by airflow obstruction.

Mechanism of Action

The medication works by targeting specific receptors called beta-2 receptors located in the smooth muscles of the airways. When these receptors are activated, they trigger the muscles to relax, which results in the widening of the bronchial tubes (bronchodilation). This process facilitates easier airflow into and out of the lungs, helping to alleviate symptoms such as wheezing, chest tightness, and shortness of breath.

Primary Uses

Asthalin is commonly utilized in the management of various obstructive airway diseases, including:

  • Asthma: To provide rapid relief of acute symptoms and to prevent exercise-induced bronchospasm.
  • Chronic Obstructive Pulmonary Disease (COPD): To help manage ongoing breathing difficulties in conditions such as chronic bronchitis and emphysema.

Because of its rapid onset of action, it is frequently categorized as a "rescue" or "reliever" medication. It is designed to act quickly during sudden bouts of respiratory distress rather than serving as a long-term preventive treatment for underlying inflammation.

Regulatory References

  1. Salbutamol on WHO Essential Medicines List
  2. MedlinePlus Drug Information
  3. NIH Review of Beta Agonists

What side effects are possible with Asthalin?

Possible Side Effects and Safety Information

The safety profile of Asthalin, whose active ingredient is Salbutamol, is defined by categories of adverse reactions documented in official government regulatory sources, such as the EMA Summary of Product Characteristics (SmPC) and FDA labeling. The effects are classified by their frequency and organized by the affected System-Organ Class (SOC).

Very Common reactions include tremor. Common reactions typically involve the nervous and cardiac systems, such as headache, tachycardia (increased heart rate), palpitations, and muscle cramps. These effects may be more pronounced at the beginning of treatment or during dose increases and generally diminish with continued use.


Serious Adverse Reactions and Safety Considerations

Regulatory documents highlight several serious adverse reactions, although these are typically Rare or Very Rare. These include paradoxical bronchospasm (an immediate worsening of breathing after inhalation) and severe, immediate hypersensitivity reactions (such as angioedema or collapse). A Rare but documented metabolic concern is hypokalaemia (low serum potassium levels), which requires observation, especially in acute, severe use.

Specific safety caution is noted for patients with certain pre-existing conditions. These include cardiac disorders (such as coronary insufficiency or arrhythmias), thyrotoxicosis, and diabetes mellitus. The co-administration of non-selective beta-blocking drugs is generally discouraged due to the potential for severe bronchoconstriction and blocking of the drug's intended action. This structured information serves to neutrally describe the documented risks associated with the medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations of Asthalin (Salbutamol) overdose and the specific emergency actions required, based strictly on government regulatory product information.

Overdose of Asthalin, even acute over-inhalation, leads to manifestations primarily reflecting excessive beta-agonist activity. The most common clinical manifestations documented in regulatory labels include tachycardia (rapid heart rate), palpitations, tremor, headache, and hyperactivity.


Serious Manifestations and Required Actions

Classification Manifestation/Required Action
Serious Outcomes Hypokalaemia (low blood potassium), lactic acidosis, and cardiac arrhythmias are documented as potentially severe complications.
Emergency Action Seek immediate medical attention/advice for any suspected overdose. Call the Poison Help line or equivalent service.
Monitoring Official management includes monitoring for metabolic changes, specifically serum potassium levels and lactic acidosis.

If the usual relief from the inhaler is diminished or the duration of action is reduced, do not increase the dose; seek medical advice immediately, as this suggests a worsening underlying respiratory condition. A cardioselective beta-blocking agent is listed as the preferred antidote, but must be administered with extreme caution due to the risk of inducing severe bronchospasm.

Therapeutic Uses of Asthalin

What Asthalin Treats: Main Uses and Benefits

Asthalin (Salbutamol) is a dedicated rescue agent applied across domains where additional symptomatic support is needed for acute breathing distress. The medication is commonly used to help with symptoms related to conditions like Bronchial Asthma and Chronic Obstructive Pulmonary Disease (COPD). It is considered relevant for easing symptoms when respiratory manifestations unexpectedly worsen, and supports patients during episodes of heightened discomfort. The medication is primarily used for managing conditions presenting with acute episodes and recurrent manifestations, including asthma attacks, COPD exacerbations, and Exercise-Induced Bronchospasm (EIB).


Quick Fact: Relief for Acute Airway Distress

Therapeutic Domain Symptom Focus
Acute Symptomatic Episodes Helps address symptom clusters that may become intense or disruptive.
Exertion-Related Symptoms Relevant for managing symptoms that interfere with daily comfort during physical activity.

It is applied when patients experience cluster symptoms such as wheezing, chest tightness, and sudden-onset shortness of breath (dyspnea). When applied appropriately, the medication helps address symptoms related to heightened physiological activity, providing support that helps ease the overall symptom burden.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Asthalin (Salbutamol)?

Asthalin's eligibility is strictly defined by government regulatory agencies based on established safety and risk profiles for specific patient populations. The official labeling outlines which groups are approved, restricted, or absolutely prohibited from using the medication.


Contraindicated Populations (Absolute Non-Eligibility)

The medicine is contraindicated and must not be used by individuals with a known history of hypersensitivity or severe allergic reaction to Salbutamol or any other component in the formulation.

Age-Based Eligibility

Age Group Eligibility Status
Adults and Adolescents Approved for standard use.
Children (4 years and older) Safety and effectiveness are established for treatment (inhalation forms).
Children (under 4 years) Safety and effectiveness are not established for standard indications.

Conditional Use and Comorbidity Restrictions

Use of Asthalin is restricted and requires caution and medical monitoring for patients with certain pre-existing conditions, including cardiovascular disorders (such as coronary insufficiency or hypertension), diabetes mellitus, hyperthyroidism, and a history of convulsive disorders (seizure disorders).

Pregnancy and Lactation

Use during pregnancy is conditional and generally permitted only if the potential benefit justifies the potential risk, as adequate human studies are lacking. Caution is advised while breastfeeding, as it is not known if the drug is excreted in human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific drug–drug interactions for Asthalin (Salbutamol), classified primarily by pharmacodynamic effects and prohibitions on co-administration. Co-use with non-selective beta-blocking agents, such as Propranolol, is advised to be avoided as it may block the bronchodilatory effect of Salbutamol and risk precipitating severe bronchospasm.

Documented Interaction Patterns

The co-administration of Asthalin with several common drug classes poses an additive risk of hypokalemia (low potassium). This includes non-potassium-sparing diuretics, xanthine derivatives (like Theophylline), and systemic or high-dose inhaled corticosteroids, as these combinations may potentiate the effect on potassium levels.

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) or Tricyclic Antidepressants (TCAs) requires extreme caution. Regulatory labeling specifies that this caution applies to patients currently treated with these agents or within two weeks of their discontinuation, due to the risk of potentiating Asthalin's action on the vascular system.

Asthalin co-administration may also decrease serum digoxin levels, and official labeling advises that serum levels of Digoxin be considered for monitoring. Official regulatory sources generally note that there is insufficient information to confirm the safety of combining Salbutamol with herbal remedies or supplements.

Mechanism of Action

How Asthalin Works: Mechanism of Action

Asthalin's mechanism is based on the selective agonism of beta2-Adrenergic Receptors (beta2-ARs) located predominantly on the bronchial smooth muscle cells. The binding of the active substance to the beta2-AR initiates a molecular cascade via the Gs protein. This complex activates the enzyme adenylyl cyclase, leading to a sharp increase in the intracellular concentration of the second messenger, cyclic AMP (cAMP).

Elevated cAMP levels activate Protein Kinase A, which ultimately causes a reduction in the free intracellular calcium ions ( Ca^2+) required for muscle contraction. This chemical sequence produces the relaxation of airway smooth muscle, resulting in the system-level physiological effect of bronchodilation (widening of the air passages). A secondary mechanistic consequence involves the action on mast cells, which reduces the release of inflammatory mediators that can cause smooth muscle contraction in the airways.

Dosage and Administration Information

How to Use Asthalin: Administration Guidelines

Asthalin (salbutamol) is used according to specific instructions that define the route, dosage, and frequency of administration. This section describes the general principles of use and the limits of the medication, without providing individualized medical advice.


Administration Scope

Feature Guideline
Route of Administration The primary administration route is Oral Inhalation, typically via a Metered-Dose Inhaler (MDI) or nebulizer. Oral forms (tablets, syrup) and parenteral forms (IV, Subcutaneous, Intramuscular) are also utilized for systemic use or acute hospital settings.
Dosing Schedule (Adults) Acute Relief (Inhalation): The standard starting dose is 100 mu g to 200 mu g (1 to 2 actuations) as needed for symptom management. Oral Tablets: Dosing typically ranges from 2 mg to 4 mg, taken three or four times daily, with a maximum dose of up to 8 mg four times a day.
Preparation Requirements Proper use involves priming the MDI device before initial use or if it has been unused for more than two weeks, by releasing test sprays into the air. Nebulizer solution may require dilution with 0.9% sodium chloride solution if prolonged treatment time is necessary.
Age-Group Administration Pediatric Patients: Dosing is weight- or age-dependent, often using lower inhalation doses or syrup. Older Adults: A lower starting oral dose (e.g., 2 mg three or four times daily) is generally recommended, with gradual adjustment.

Use Protocol and Frequency

Administration of the inhalation forms is primarily as needed (PRN) for rapid relief, with a mandatory minimum interval (e.g., four to six hours) between doses unless required for severe, acute events under medical supervision. Correct synchronization of inhalation with canister actuation is necessary, and spacer devices are recommended for individuals with poor coordination to ensure optimal drug delivery. If a scheduled oral dose is missed, it should be taken promptly unless the next scheduled dose is near, in which case the missed dose is skipped to prevent doubling the dose.

Recent Clinical Evidence

Research exploring Asthalin primarily involves short-term Randomized Controlled Trials (RCTs) and Systematic Reviews focused on acute symptoms of bronchial asthma. These studies examine functional outcomes related to breathing, such as FEV1 and PEFR, and patient-reported measures of discomfort in both adult and pediatric populations.

Research describes objective measurements of changes in airway function following administration, with studies reporting patterns where the observed onset of changes occurred over defined time intervals. However, large observational studies evaluating real-world usage reported that high-frequency prescribing patterns were associated with certain outcomes related to increased symptom activity.

Evidence also exists for Exercise-Induced Bronchospasm (EIB), where controlled crossover trials monitor whether studies documented a measured reduction in airway function ( FEV1) following an exercise challenge. Studies described patterns indicating a diminished pattern of difference in measured FEV1 was observed in some populations with regular daily use. For Chronic Obstructive Pulmonary Disease (COPD), RCTs and cohort studies examined its use during episodes of heightened symptom activity, reporting objective measurements of functional outcomes related to breathing. Findings were mixed regarding its use as an isolated therapy versus combination therapy for acute relief.

Overall, most evidence is derived from short-term study periods, meaning long-term effects are not fully established. Data for certain groups remain insufficient, particularly for very older adults or pregnancy-related populations. The evidence derived from settings with varying symptom burdens indicates an association between frequent use and certain outcomes, but comparative evidence is lacking to establish a causal relationship.

Frequently Asked Questions (FAQ)

Common questions about Asthalin (FAQ)


Q: Is Asthalin the same as Ventolin, and what are the key differences?

Asthalin and Ventolin are both common brand names for the same active ingredient: salbutamol (which is also known as albuterol in the United States). Official regulatory sources confirm that all these products contain the same core bronchodilator medicine. Any differences are typically related to the manufacturer, the specific device design, or the propellant used, not the core medication.

Q: How quickly does Asthalin start working after I take it?

Asthalin is classified as a Short-Acting Beta-Agonist (SABA), which means it is intended for rapid relief. According to official product information, the bronchodilating effect begins quickly, typically within a few minutes after inhalation.

Q: How long does the effect of Asthalin typically last?

As a rapid-relief medication, the therapeutic effects of Asthalin generally last for approximately four to six hours. This duration is consistent with its pharmacological classification as a Short-Acting Beta-Agonist.

Q: Is it normal to feel shaky or have a fast heart rate after using an Asthalin inhaler?

Yes, regulatory documents list common side effects that include feeling shaky (tremor), and experiencing a fast heart rate (tachycardia) or forceful/fluttering heartbeats (palpitations). These effects are related to the way the drug works and may be more noticeable when treatment is initiated.

Q: Does using Asthalin too often reduce its effectiveness over time?

Official guidance indicates that if there is an increased need for the rescue inhaler, it may signal that the underlying condition is worsening and warrants medical review. Regulatory warnings stress that this should not be ignored.

Q: Can Asthalin be used to prevent an asthma attack before exercise?

Yes, salbutamol is indicated in official labeling for the prevention of symptoms related to exercise, known as Exercise-Induced Bronchospasm (EIB). Product information indicates that administration is typically done shortly before beginning the exercise.

Q: Is Asthalin generally well-tolerated by the elderly?

The use of the drug in older adults is documented in regulatory materials. For oral forms, a lower starting dose may be recommended initially, and official guidance notes that any dose adjustment is determined based on the individual’s response to the medication.

Q: Why do I sometimes cough right after inhaling Asthalin?

Official adverse reaction sections note that oropharyngeal (mouth and throat) irritation and cough are possible side effects of inhaled salbutamol. In very rare instances, an immediate and severe worsening of breathing, called paradoxical bronchospasm, may occur.

Q: Can children safely use Asthalin, and what's the general age range?

Regulatory information states that the safety and effectiveness of the inhalation forms of salbutamol are established for pediatric patients aged 4 years and older. The safety and effectiveness of Asthalin are not established for routine use in children under the age of 4.

Q: Is Asthalin safe to use during pregnancy or while breastfeeding?

Official prescribing information states that use during pregnancy is conditional and is generally permitted only if the potential benefit justifies the potential risk, as human studies are often limited. Caution is advised while breastfeeding because it is not confirmed whether the drug passes into human milk.

Q: Are there any common over-the-counter medications that interact with Asthalin?

Interactions are officially listed for specific prescription drug classes, such as non-selective beta-blockers, which can be present in some non-prescription eye drops. For other common over-the-counter medicines, official regulatory sources advise caution with any co-administered medicine.

Q: Should I avoid caffeine or alcohol when I am using Asthalin?

Official regulatory guidance specifically warns that consuming alcohol may worsen central nervous system side effects, such as dizziness or sleepiness. Regulatory product information does not typically contain warnings regarding dietary caffeine consumption.

Q: What happens if I accidentally take two puffs of Asthalin close together?

An accidental dose increase may cause common side effects, such as tremor or a fast heart rate, to become more pronounced. Official product information notes that the maximum number of puffs recommended for use in a 24-hour period should not be exceeded.

Q: Why do some people use Asthalin tablets instead of the inhaler?

Asthalin is available in both inhalation and oral forms, such as tablets. Inhalation is often the primary method for acute symptoms because it delivers the medicine directly to the lungs for a quicker, more localized effect. Tablets may be used for specific clinical reasons, though they typically have a slower onset and may cause more systemic side effects.

Q: How should Asthalin inhalers be stored to keep them effective?

To maintain the drug's integrity, official product information mandates storing the inhaler at or below 30 C and protecting it from direct heat, moisture, and light. The pressurized canister should never be exposed to temperatures over 50 C or punctured.

Q: What's the difference between Asthalin HFA and other types of Asthalin inhalers?

HFA refers to the type of propellant (hydrofluoroalkane) used to deliver the medicine from the canister. This is a common modern propellant that replaced older types like CFCs. The propellant affects the drug delivery system, while the active medicine (salbutamol) remains the same.

Q: Can people with high blood pressure use Asthalin?

Official warnings state that the use of Asthalin requires caution in patients with cardiovascular issues, including hypertension (high blood pressure). This is because the drug can potentially cause an increased heart rate or changes in blood pressure, and its use warrants medical supervision.

Q: Is a slight metallic taste after using the inhaler a normal side effect of Asthalin?

Official regulatory documents list altered taste as a possible side effect related to the use of the inhaled medicine. This is a recognized occurrence following actuation of the inhaler device.

Q: Can Asthalin affect my ability to drive or operate machinery?

Asthalin may cause certain side effects like dizziness or tremor (shakiness). If these effects occur, official guidance states that patients should not drive or operate machinery until the side effects have fully resolved.

Q: If I only use Asthalin occasionally, will it still cause side effects?

Side effects, such as tremor or a fast heart rate, are listed in official documents and can occur with any use. They are, however, sometimes noted to be more pronounced when treatment is first started.

Q: How do I know when my Asthalin inhaler is empty?

Most modern inhaler canisters include a dose counter that displays the number of remaining doses. Regulatory information advises patients to monitor this counter closely, as the device may continue to spray propellant even after the medicine is used up.

Q: Can Asthalin be used by people who have diabetes?

Official product information advises caution when Asthalin is used by patients with diabetes mellitus. This is because the medication is known to potentially influence blood glucose levels, and its use warrants medical supervision.

Q: Does Asthalin show up on drug tests?

Salbutamol is a substance that can be detected in biological samples. The World Anti-Doping Agency (WADA) classifies salbutamol as a restricted substance, but its use is generally permitted for therapeutic reasons within specified dosage limits, often requiring a medical exemption.

Q: What is the difference between Asthalin and a combination inhaler?

Asthalin is a single-component product, containing only the active bronchodilator salbutamol. Combination inhalers, as classified by regulatory bodies, contain two or more active medications, often pairing a bronchodilator with a different class of medicine, such as an inhaled corticosteroid.

Q: Can Asthalin be used with a nebulizer, and what does that mean?

Yes, Asthalin is approved for use as a solution for nebulization. Nebulization involves using a device to transform the liquid medicine into a fine, easily inhaled mist, a method often used for patients who cannot use an inhaler effectively or during severe breathing difficulty.

Q: What are the signs that Asthalin is working correctly?

The primary mechanism of action is the relaxation of the muscles in the airways (bronchodilation). When the drug is working correctly, this should result in the rapid and measurable relief of acute breathing symptoms, such as shortness of breath or wheezing.

Q: Does Asthalin interact with common supplements like multivitamins or herbal teas?

Official regulatory sources usually note that there is insufficient information available to confirm the safety of combining salbutamol with herbal remedies or dietary supplements. Official product information advises caution with any co-administered substance.

Q: What is the maximum number of times I can use Asthalin in one day?

Official dosing guidelines typically state that for the routine relief of symptoms, a dose should not be repeated more often than every four to six hours. For inhalation, the maximum number of puffs should not be exceeded according to official product information.

Q: Can using a spacer help reduce the side effects of Asthalin?

Spacer devices are officially recommended to improve coordination and optimize drug delivery to the lungs. Using a spacer can help ensure a higher proportion of the medicine reaches the airways.

Q: Can people with glaucoma safely use Asthalin?

Glaucoma is mentioned in regulatory warnings as a condition requiring caution, particularly when salbutamol is used in a nebulizer with other certain medicines. Official prescribing information notes that patients with glaucoma should follow proper administration techniques to prevent the nebulized mist from directly contacting the eyes.

Q: Is it possible to have an allergic reaction to Asthalin?

Yes, Asthalin is contraindicated and should not be used in anyone with a known history of severe allergic reaction or hypersensitivity to salbutamol or any of the inactive ingredients. Severe, immediate allergic responses are listed as rare adverse reactions in official documents.

Q: What is the shelf life of an Asthalin inhaler?

The shelf life is determined by the expiration date (EXP) that is printed on the packaging and the canister itself. Official guidance advises that the product should not be used past this date as the medication's effectiveness may be compromised.

Q: Can Asthalin cause sleep disturbances or insomnia?

Side effects on the nervous system, such as tremor, headache, and restlessness, are known effects of beta-agonists. Such central nervous system stimulation could potentially contribute to difficulties with sleep.

Q: What is the role of Asthalin in managing Chronic Obstructive Pulmonary Disease (COPD)?

Official regulatory documents approve salbutamol for managing reversible airway obstruction, which includes its use in Chronic Obstructive Pulmonary Disease (COPD). It is typically utilized for rapid relief during periods of increased symptoms.

Q: Is the proper technique for using an Asthalin inhaler different for adults versus children?

While the general principle of inhalation is the same, regulatory guidance acknowledges that young children often struggle with coordinating their breath with the inhaler actuation. For this reason, the use of a spacer device and adult supervision is often recommended for pediatric patients.

How should Asthalin be stored and disposed of?

Storage and Disposal Requirements

Asthalin (Salbutamol) must be stored under specific conditions to maintain stability, particularly for the pressurized inhaler and light-sensitive nebulizer solutions.


Official Storage Constraints

  • Temperature: Store the product at or below 30°C. It must not be refrigerated or frozen.
  • Protection: Protect the medicine from direct light, heat, and moisture.
  • Pressurized Canister: The inhaler canister must not be exposed to temperatures exceeding 50°C and should not be pierced or punctured.
  • Child Safety: Keep the medication out of the sight and reach of children.

Disposal and Handling

  • Pressurized Device: The used or empty canister must not be burned or incinerated.
  • Nebulizer Vials: Once opened, the solution must be used immediately, and any remaining contents must be discarded.
  • General Disposal: Dispose of all unused or expired product strictly in accordance with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Asthalin found in:

A-Z Index: